Aurobindo Pharma is currently trading at Rs. 1165.00, up by 41.85 points or 3.73% from its previous closing of Rs. 1123.15 on the BSE.
The scrip opened at Rs. 1128.00 and has touched a high and low of Rs. 1166.00 and Rs. 1128.00 respectively. So far 53,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1171.20 on 09-Dec-2014 and a 52 week low of Rs. 295.50 on 13-Dec-2013.
Last one week high and low of the scrip stood at Rs. 1171.20 and Rs. 1108.00 respectively. The current market cap of the company is Rs. 33,973.00 crore.
The promoters holding in the company stood at 54.10%, while Institutions and Non-Institutions held 35.67% and 10.22% respectively.
Aurobindo Pharma has received approval for the issue of equity shares through qualified institutions placement up to $350 million. The board at its meeting held on December 10, 2014 has approved for the same. At the aforesaid meeting, it has also been decided to hold a general meeting of the members of the Company for the above purpose on January 21, 2015.
Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.
